Qinghao Wang1,2, Zixin Zhang1,2, Hao Zhou1

  • 1The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Science, Hunan Normal University, Changsha, 410081, China.

Journal of Cancer
|September 23, 2024
PubMed
概括

肝癌 (HCC) 中的乙氨基透与患者的存活率相关. 一种使用四个与乙氨基酸相关的基因 (RAMP3,G6PD,SSRP1,PLOD2) 的新型风险模型可以预测结果并指导精确的HCC治疗.